Otto Frey
About
Otto Frey is a scholar working on Pharmacology, Epidemiology and Molecular Medicine.
According to data from OpenAlex, Otto Frey has authored 47 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pharmacology, 26 papers in Epidemiology and 10 papers in Molecular Medicine. Recurrent topics in Otto Frey's work include Antibiotics Pharmacokinetics and Efficacy (38 papers), Pneumonia and Respiratory Infections (14 papers) and Sepsis Diagnosis and Treatment (12 papers). Otto Frey is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (38 papers), Pneumonia and Respiratory Infections (14 papers) and Sepsis Diagnosis and Treatment (12 papers). Otto Frey collaborates with scholars based in Germany, Australia and United States. Otto Frey's co-authors include Jason A. Roberts, William Hope, Mohd H. Abdul‐Aziz, Jeffrey Lipman, Alexander A. Vinks, Ursula Theuretzbacher, Johan W. Mouton, Timothy Felton, Joseph L. Kuti and Jerome J. Schentag and has published in prestigious journals such as Scientific Reports, Antimicrobial Agents and Chemotherapy and The Lancet Infectious Diseases.
In The Last Decade
Otto Frey
43 papers receiving 1.4k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Otto Frey Germany | 18 | 1.1k | 660 | 411 | 334 | 238 | 47 | 1.5k | ||
| Marta Ulldemolins Spain | 13 | 888 0.8× | 564 0.9× | 326 0.8× | 281 0.8× | 148 0.6× | 24 | 1.1k | ||
| Maya Hites Belgium | 24 | 777 0.7× | 629 1.0× | 335 0.8× | 302 0.9× | 417 1.8× | 77 | 1.5k | ||
| Menino Osbert Cotta Australia | 22 | 841 0.7× | 643 1.0× | 325 0.8× | 665 2.0× | 170 0.7× | 72 | 1.5k | ||
| Arantxa Isla Spain | 24 | 951 0.8× | 451 0.7× | 393 1.0× | 200 0.6× | 219 0.9× | 59 | 1.6k | ||
| Kazuro Ikawa Japan | 23 | 1.2k 1.1× | 735 1.1× | 526 1.3× | 261 0.8× | 565 2.4× | 127 | 1.9k | ||
| Olaf Burkhardt Germany | 27 | 728 0.6× | 1.0k 1.5× | 390 0.9× | 266 0.8× | 422 1.8× | 56 | 2.1k | ||
| Michael Zöller Germany | 24 | 714 0.6× | 548 0.8× | 256 0.6× | 175 0.5× | 309 1.3× | 84 | 1.4k | ||
| Mieke Carlier Belgium | 19 | 944 0.8× | 515 0.8× | 379 0.9× | 281 0.8× | 68 0.3× | 24 | 1.1k | ||
| Claire Roger France | 22 | 943 0.8× | 626 0.9× | 398 1.0× | 303 0.9× | 308 1.3× | 119 | 1.9k | ||
| Scott Briscoe Australia | 10 | 764 0.7× | 411 0.6× | 270 0.7× | 253 0.8× | 87 0.4× | 10 | 1.0k |
Countries citing papers authored by Otto Frey
Since
Specialization
Citations
This map shows the geographic impact of Otto Frey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Otto Frey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Otto Frey more than expected).
Fields of papers citing papers by Otto Frey
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Otto Frey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Otto Frey. The network helps show where Otto Frey may publish in the future.
Co-authorship network of co-authors of Otto Frey
This figure shows the co-authorship network connecting the top 25 collaborators of Otto Frey. A scholar is included among the top collaborators of Otto Frey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Otto Frey. Otto Frey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Klein, Sabrina, Yvonne Müller, Otto Frey, et al.. (2025). Exploratory analysis of long-term suppressive therapy with dalbavancin in ventricular assist device infections caused by Staphylococcus aureus. Scientific Reports. 15(1). 15515–15515.
2.
Liebchen, Uwe, Otto Frey, Sabrina Klein, et al.. (2024). Model-Based Dose Identification of Dalbavancin for Long-Term Suppressive Outpatient Treatment of Ventricular Assist Device Infections. Antibiotics. 13(11). 1103–1103.
3.
Groote, Thilo von, et al.. (2024). No Sequestration of Commonly Used Anti-Infectives in the Extracorporeal Membrane Oxygenation (ECMO) Circuit—An Ex Vivo Study. Antibiotics. 13(4). 373–373.
4.
Liebchen, Uwe, Max Hübner, Georg Höfner, et al.. (2024). Serum concentrations of levosimendan and its metabolites OR-1855 and OR-1896 in cardiac surgery patients with cardiopulmonary bypass. Frontiers in Cardiovascular Medicine. 11. 1406338–1406338.
5.
Brinkmann, Alexander, Anka C. Roehr, Otto Frey, et al.. (2024). Predictive performance of multi-model approaches for model-informed precision dosing of piperacillin in critically ill patients. International Journal of Antimicrobial Agents. 64(4). 107305–107305.
6.
Richter, Daniel, Otto Frey, Anka C. Röhr, et al.. (2023). Software- and TDM-Guided Dosing of Meropenem Promises High Rates of Target Attainment in Critically Ill Patients. Antibiotics. 12(7). 1112–1112.
7.
Brinkmann, Alexander, Anka C. Roehr, Otto Frey, et al.. (2023). Towards model-informed precision dosing of piperacillin: multicenter systematic external evaluation of pharmacokinetic models in critically ill adults with a focus on Bayesian forecasting. Intensive Care Medicine. 49(8). 966–976.
8.
Wicha, Sebastian G., Otto Frey, Thomas Fuchs, et al.. (2022). Population pharmacokinetics and toxicodynamics of continuously infused linezolid in critically ill patients. International Journal of Antimicrobial Agents. 59(5). 106572–106572.
9.
Fuchs, Juri, Otto Frey, Daniel Hornuß, et al.. (2022). Study protocol of REpeat versus SIngle ShoT Antibiotic prophylaxis in major Abdominal Surgery (RESISTAAS I): a prospective observational study of antibiotic prophylaxis practice for patients undergoing major abdominal surgery. BMJ Open. 12(9). e062088–e062088.
10.
Richter, Daniel, Otto Frey, Anka C. Röhr, et al.. (2021). Personalized Piperacillin Dosing for the Critically Ill: A Retrospective Analysis of Clinical Experience with Dosing Software and Therapeutic Drug Monitoring to Optimize Antimicrobial Dosing. Antibiotics. 10(6). 667–667.
11.
Frey, Otto, et al.. (2021). Excessive unbound cefazolin concentrations in critically ill patients receiving veno-arterial extracorporeal membrane oxygenation (vaECMO): an observational study. Scientific Reports. 11(1). 16981–16981.
12.
Eisert, Albrecht, Christian Lanckohr, Otto Frey, et al.. (2021). Comparison of two empirical prolonged infusion dosing regimens for meropenem in patients with septic shock: A two-center pilot study. International Journal of Antimicrobial Agents. 57(3). 106289–106289.
13.
Wicha, Sebastian G., Otto Frey, Anka C. Roehr, et al.. (2020). Pharmacokinetics of tigecycline in critically ill patients with liver failure defined by maximal liver function capacity test (LiMAx). Annals of Intensive Care. 10(1). 106–106.
14.
Hagel, Stefan, Andreas Höhn, Alexander Brinkmann, et al.. (2019). Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial. Trials. 20(1). 330–330.
15.
Brinkmann, Alexander, Anka C. Röhr, Otto Frey, et al.. (2018). S2k-Leitlinie der PEG zur kalkulierten parenteralen Initialtherapie bakterieller Erkrankungen bei Erwachsenen. Der Anaesthesist. 67(12). 936–949.
16.
Brinkmann, Alexander, et al.. (2016). Therapeutisches Drug Monitoring und individualisierte Dosierung von Antibiotika bei der Sepsis. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 113(2). 82–93.
17.
Roehr, Anka C., Otto Frey, Niklas Thon, et al.. (2016). Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational study. Critical Care. 20(1). 343–343.
18.
Frey, Otto, et al.. (2016). Population pharmacokinetics of meropenem in elderly patients: dosing simulations based on renal function. European Journal of Clinical Pharmacology. 73(3). 333–342.
19.
Alobaid, Abdulaziz S., Alexander Brinkmann, Otto Frey, et al.. (2015). What is the effect of obesity on piperacillin and meropenem trough concentrations in critically ill patients?. Journal of Antimicrobial Chemotherapy. 71(3). 696–702.
20.
Roberts, Jason A., Mohd H. Abdul‐Aziz, Jeffrey Lipman, et al.. (2014). Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. The Lancet Infectious Diseases. 14(6). 498–509.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Marta Ulldemolins Breakdown of academic impact, for papers by Maya Hites Breakdown of academic impact, for papers by Menino Osbert Cotta Breakdown of academic impact, for papers by Arantxa Isla Breakdown of academic impact, for papers by Kazuro Ikawa Breakdown of academic impact, for papers by Olaf Burkhardt Breakdown of academic impact, for papers by Michael Zöller Breakdown of academic impact, for papers by Mieke Carlier Breakdown of academic impact, for papers by Claire Roger Breakdown of academic impact, for papers by Scott Briscoe